Home Semiconductor & Electronics Electronic Components Artemisinin Combination Therapy (ACT) Market

Artemisinin Combination Therapy (ACT) Market Size, Share & Trends Analysis Report By Type (Artemether+Lumefantrine, Artesunate+Amodiaquine, Dihydroartemisinin+Piperaquine, Artesunate+Mefloquine, Artesunate+Sulfadoxine-Pyrimethamine, Pyronaridine-Artesunate, Other), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Drug Stores & Retail Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 04, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Artemisinin Combination Therapy (ACT) Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Artemether+Lumefantrine
    2. Artesunate+Amodiaquine
    3. Dihydroartemisinin+Piperaquine
    4. Artesunate+Mefloquine
    5. Artesunate+Sulfadoxine-Pyrimethamine
    6. Pyronaridine-Artesunate
    7. Other
  2. Artemisinin Combination Therapy (ACT) Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Online Pharmacies
    3. Drug Stores & Retail Pharmacies
  3. Regional Artemisinin Combination Therapy (ACT) Market
    1. North America
      1. North America Artemisinin Combination Therapy (ACT) Market By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      2. North America Artemisinin Combination Therapy (ACT) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
      3. U.S.
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      4. Canada
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
    2. Europe
      1. Europe Artemisinin Combination Therapy (ACT) Market By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      2. Europe Artemisinin Combination Therapy (ACT) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
      3. U.K.
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      4. Germany
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      5. France
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      6. Spain
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      7. Italy
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      8. Russia
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      9. Nordic
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      10. Benelux
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      11. Rest of Europe
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
    3. APAC
      1. APAC Artemisinin Combination Therapy (ACT) Market By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      2. APAC Artemisinin Combination Therapy (ACT) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
      3. China
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      4. Korea
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      5. Japan
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      6. India
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      7. Australia
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      8. Taiwan
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      9. South East Asia
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      10. Rest of Asia-Pacific
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
    4. Middle East and Africa
      1. Middle East and Africa Artemisinin Combination Therapy (ACT) Market By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      2. Middle East and Africa Artemisinin Combination Therapy (ACT) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
      3. UAE
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      4. Turkey
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      5. Saudi Arabia
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      6. South Africa
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      7. Egypt
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      8. Nigeria
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      9. Rest of MEA
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
    5. LATAM
      1. LATAM Artemisinin Combination Therapy (ACT) Market By Type 2022-2034 (USD MILLION/ Units)
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
      2. LATAM Artemisinin Combination Therapy (ACT) Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Online Pharmacies
        3. Drug Stores & Retail Pharmacies
      3. Brazil
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      4. Mexico
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      5. Argentina
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      6. Chile
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      7. Colombia
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
      8. Rest of LATAM
        1. Artemether+Lumefantrine
        2. Artesunate+Amodiaquine
        3. Dihydroartemisinin+Piperaquine
        4. Artesunate+Mefloquine
        5. Artesunate+Sulfadoxine-Pyrimethamine
        6. Pyronaridine-Artesunate
        7. Other
        8. Hospital Pharmacies
        9. Online Pharmacies
        10. Drug Stores & Retail Pharmacies
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.